CXCR4 and neoplasm: Interestingly, in the comparison of primary tumours with different capability to metastasize, primary samples that did not metastasize showed significantly lower expression of the chemokine receptor CXCR4 than primary samples from patients who later developed metastases (P < 0.001) (Table 4 and Figures 2 and 3(a)).